Artemisinin Imp-C is a sesquiterpene lactone derivative featuring a hydroxyl-substituted cyclohexenone core and a methylbutyl side chain. It retains the parent drug's tricyclic framework but lacks the endoperoxide bridge, instead exhibiting a secondary hydroxyl group at the C-10 position. This structural divergence arises from a hydrogenation byproduct during semi-synthetic artemisinin production. Functions as an HPLC reference standard for quantifying process-related impurities in artemisinin-based pharmaceuticals.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1042882 โ | 25 mg | โ |
C[C@@H]1CC[C@H]2C(=CO[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C
InChI=1S/C15H22O4/c1-9-4-5-11-10(2)8-16-13-15(11)12(9)6-7-14(3,17-13)18-19-15/h8-9,11-13H,4-7H2,1-3H3/t9-,11+,12+,13-,14-,15+/m1/s1
UKXCIQFCSITOCY-VLDCTWHGSA-N